Antimicrobial Susceptibility Testing Market Report
Published Date: 22 April 2026 | Report Code: antimicrobial-susceptibility-testing
Antimicrobial Susceptibility Testing Market Size, Share, Industry Trends and Forecast to 2033
This report provides a comprehensive analysis of the Antimicrobial Susceptibility Testing market, focusing on market dynamics, trends, regional insights, and future forecasts between 2023 and 2033.
Key Takeaways
- Global market valued at $2.50 Billion in 2023 and projected to reach $4.91 Billion by 2033 at a 6.8% CAGR.
- North America is both the largest and the fastest-growing region, reflecting strong diagnostic infrastructure and investment.
- Adoption of automated systems and molecular diagnostics is accelerating demand across hospitals, diagnostic labs, and research institutes.
- Major players include BioMerieux, Thermo Fisher Scientific, Becton Dickinson, and Cepheid, driving technology and service innovation.
Antimicrobial Susceptibility Testing Market Report — Executive Summary
The Antimicrobial Susceptibility Testing market is positioned for steady expansion from 2023 to 2033, driven by the escalation of antimicrobial resistance and the need for precise diagnostic results to guide therapy. Market size stands at $2.50 Billion in 2023 and is expected to reach $4.91 Billion by 2033 at a 6.8% CAGR. Investment in automated testing platforms, integration of molecular diagnostic techniques, and increased funding for infectious disease infrastructure are shaping adoption across hospitals, diagnostic laboratories, research institutes, and pharmaceutical companies. Product segmentation spans manual and automated systems plus consumables, while methodologies include broth micro-dilution, agar diffusion, and epidemiological susceptibility testing. Regional dynamics are led by North America, supported by established lab networks and R&D activity. Competitive activity centers on technology upgrades, faster turnaround times, and expanded service offerings from key vendors such as BioMerieux, Thermo Fisher Scientific, Becton Dickinson, and Cepheid. The report structure covers market sizing, segmentation, regional outlooks, competitive landscape, and trend analysis to aid strategic decision-making.
Key Growth Drivers
- Rising prevalence of antibiotic-resistant infections increases demand for reliable susceptibility testing and targeted therapies.
- Advances in automation and digital platforms shorten turnaround times and expand throughput in clinical and reference laboratories.
- Greater healthcare spending and diagnostic infrastructure investments boost procurement across hospitals and diagnostic centers.
- Integration of molecular diagnostics complements conventional methods, improving detection accuracy and clinician confidence.
- Research and development by leading firms advances test formats, driving commercialization and wider adoption.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $2.50 Billion |
| CAGR (2023-2033) | 6.8% |
| 2033 Market Size | $4.91 Billion |
| Top Companies | BioMerieux, Thermo Fisher Scientific, Becton Dickinson, Cepheid |
| Last Modified Date | 22 April 2026 |
Antimicrobial Susceptibility Testing Market Overview
Customize Antimicrobial Susceptibility Testing Market Report market research report
- ✔ Get in-depth analysis of Antimicrobial Susceptibility Testing market size, growth, and forecasts.
- ✔ Understand Antimicrobial Susceptibility Testing's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Antimicrobial Susceptibility Testing
What is the Market Size & CAGR of Antimicrobial Susceptibility Testing Market Report market in 2023?
Antimicrobial Susceptibility Testing Industry Analysis
Antimicrobial Susceptibility Testing Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Antimicrobial Susceptibility Testing Market Report Market Analysis Report by Region
Europe Antimicrobial Susceptibility Testing Market Report:
Europe grows from $0.64 Billion in 2023 to $1.26 Billion in 2033, driven by heightened focus on antimicrobial stewardship, expanded diagnostic funding across hospitals and labs, and adoption of advanced testing methodologies.Asia Pacific Antimicrobial Susceptibility Testing Market Report:
Asia Pacific advances from $0.49 Billion in 2023 to $0.97 Billion in 2033, supported by expanding diagnostic infrastructure, rising awareness of antimicrobial resistance, and increased procurement by clinical laboratories and research centers.North America Antimicrobial Susceptibility Testing Market Report:
North America is the largest and fastest-growing region, expanding from $0.83 Billion in 2023 to $1.64 Billion in 2033. Growth reflects extensive laboratory networks, rapid uptake of automation, strong R&D activity, and significant healthcare investment supporting AST deployment.South America Antimicrobial Susceptibility Testing Market Report:
Middle East & Africa Antimicrobial Susceptibility Testing Market Report:
Middle East and Africa progress from $0.32 Billion in 2023 to $0.63 Billion in 2033, reflecting investments in healthcare infrastructure, rising diagnostics adoption, and initiatives to improve infectious disease detection and management.Tell us your focus area and get a customized research report.
Research Methodology
Antimicrobial Susceptibility Testing Market Analysis By Product Type
In 2023, the product types like Broth Micro-dilution and Automated Systems accounted for significant shares. Broth Micro-dilution is expected to hold a dominant market share of approximately 64.16% in 2023, while Automated Systems are anticipated to grow from $0.58 billion to $1.15 billion by 2033.
Antimicrobial Susceptibility Testing Market Analysis By Methodology
Broth micro-dilution techniques lead the AST methodologies held an expected market share of 64.16% in 2023. Agar diffusion techniques followed with 23.34% of the market share, showcasing their critical role in susceptibility testing for clinical settings.
Antimicrobial Susceptibility Testing Market Analysis By Organism Type
The bacteria segment dominates the market, holding a significant 64.16% well into the forecasted period. The fungi and viruses segments are also growing but have smaller market shares of 23.34% and 12.5% respectively.
Antimicrobial Susceptibility Testing Market Analysis By End User
Hospitals lead this segment with a market share of 55.57% in 2023, expected to maintain steady growth due to the high patient turnover and sheer volume in diagnostic testing. Diagnostic laboratories and research institutes follow closely with shares of 24.52% and 9.98%, respectively.
Antimicrobial Susceptibility Testing Market Analysis By Region
Geographically, North America has a commanding presence, while regions like Asia Pacific are expected to witness rapid growth, attributed to increasing healthcare investments and rising awareness of antimicrobial resistance. Europe remains strong due to regulatory requirements for high standards in testing.
Antimicrobial Susceptibility Testing Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Antimicrobial Susceptibility Testing Industry
BioMerieux:
A leading company specializing in the development of microbiological tools, BioMerieux delivers robust solutions for Infectious Disease testing and is well-known for its advanced AST products.Thermo Fisher Scientific:
Known for cutting-edge technology, Thermo Fisher provides a range of AST solutions, innovative products, and advanced laboratory services, aiding in combating antimicrobial resistance.Becton Dickinson:
Becton Dickinson's comprehensive product line in Diagnostic tools makes it a crucial player in the market, focusing on enhancing patient and laboratory outcomes in susceptibility testing.Cepheid:
Cepheid is renowned for its automated molecular testing, and offers groundbreaking solutions in rapid diagnostic testing, impacting significantly on antibiotic susceptibility testing.We're grateful to work with incredible clients.
FAQs
What is the Antimicrobial Susceptibility Testing Market Report?
A market analysis reporting a $2.50 Billion size in 2023 and projecting $4.91 Billion by 2033, with a 6.8% CAGR, covering segments, regional dynamics, and vendor activity.
How big is the market in 2023?
The market size in 2023 is $2.50 Billion, as reported in the input data for the forecast and regional breakdowns.
What is CAGR of the market?
The forecasted compound annual growth rate for the period 2023 to 2033 is 6.8%, based on the provided market projections.
Which region is the largest in this market?
North America is identified as the largest region, supported by strong diagnostic infrastructure and significant adoption of automated testing systems.
Who are the top companies operating in this market?
Key companies cited in the input include BioMerieux, Thermo Fisher Scientific, Becton Dickinson, and Cepheid, active across product and service offerings.
Why is demand for AST solutions increasing?
Demand is rising due to growing antimicrobial resistance, the need for accurate diagnostics, investments in laboratory capacity, and the push for faster, automated testing workflows.
What are common product types in the market?
Product categories listed include Manual Systems, Automated Systems, and Consumables, reflecting laboratory workflows and testing formats.
How is the market segmented by methodology?
Methodologies detailed include Broth Micro-dilution, Agar Diffusion, and Epidemiological Susceptibility Testing, representing established testing approaches.
Which end users drive adoption of AST services?
Hospitals, Diagnostic Laboratories, Research Institutes, and Pharmaceutical Companies are the primary end users influencing procurement and utilization.